No black box warning on record for Ogsiveo

As of the latest FDA labeling reviewed, Ogsiveo (NIROGACESTAT) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ogsiveo medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Diarrhea : Severe diarrhea can occur. Monitor and dose modify for Grade 3-4 diarrhea. ( 5.1 ) Ovarian Toxicity : Female reproductive function and fertility may be impaired. Advise females of reproductive potential of the potential risk prior to treatment and monitor routinely. ( 5.2 ) Hepatotoxicity : Elevated AST and ALT can occur. Monitor AST and ALT regularly and modi

No black box warning on record for Ogsiveo

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Diarrhea : Severe diarrhea can occur. Monitor and dose modify for Grade 3-4 diarrhea. ( 5.1 ) Ovarian Toxicity : Female reproductive function and fertility may be impaired. Advise females of reproductive potential of the potential risk prior to treatment and monitor routinely. ( 5.2 ) Hepatotoxicity : Elevated AST and ALT can occur. Monitor AST and ALT regularly and modi

Ogsiveo Black Box Warning

No black box warning on record for Ogsiveo

Other warnings & precautions

Ogsiveo Black Box Warning

No black box warning on record for Ogsiveo

Other warnings & precautions